APOMORPHINE

SynDRA canonical compound SYN0000266 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ADRA2A \| ADRA2B \| ADRA2C \| CALY \| DRD1 \| DRD2 \| DRD3 \| DRD4 \| DRD5 \| HTR1A \| HTR1B \| HTR1D \| HTR2A \| HTR2B \| HTR2C \| HTR5A
Mechanism of action	dopamine receptor agonist
Indication	parkinson's disease
Disease area	neurology/psychiatry

All known targets

(-)-Apomorphine
apomorphin
L-Apomorphine
apomorphine hydrochloride
apomorphine hydrochloride hydrate
apomorphine hydrochloride hemihydrate
apomorphine HCl
apomorphine chloride
6a.beta.-aporphine-10,11-diol
Apomorphinum
APL-130277
VR-040
VR040
Apomorphine hydrochloride hemihydrate
UNII-F39049Y068
Apmorphine hydrochloride hemihydrate
Apomorphin hydrochlorid wasser (2/1)
Apomorphine hydrochloride [USP]
6abeta-Aporphine-10,11-diol hydrochloride hemihydrate
Apomorphine hydrochloride hydrate
F39049Y068
Uprima (TN)
DSSTox_RID_82721
DSSTox_CID_28159
DSSTox_GSID_48185
Apomorphine hydrochloride (USP)
58-00-4 (Parent)
CHEBI:31228
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate
Apomorphine SL
Apomorphine HCl
Apomorphine chloride
(R)-(-)-Apomorphine hydrochloride
Apomorphinium chloride
Apomorphin hydrochlorid
pomorphini hydrochloridum
Apomorphinum hydrochloricum
N-Methylnorapomorphine hydrochloride